Health Gains Reverse After Stopping 'Skinny Jabs'
New research shows weight and heart health markers deteriorate after ending GLP-1 drug use, raising questions about long-term treatment for obesity in the UK.
New research shows weight and heart health markers deteriorate after ending GLP-1 drug use, raising questions about long-term treatment for obesity in the UK.
New research indicates weight loss drugs Mounjaro and Wegovy might require lifelong use to maintain results, as patients rapidly regain weight after stopping. Nearly 2 million UK adults have used the jabs.
New research from the University of Oxford shows people regain weight four times faster after stopping GLP-1 drugs than with behavioural plans. Discover the long-term implications.
Ogilvy UK's Amelia Torode supports the new HFSS advertising regulations. She argues the ban combats child obesity and forces smarter, more creative brand building. Read her full analysis.
New UK regulations restrict TV and online ads for high-fat, salt, and sugar foods. Experts debate if this will help tackle the nation's growing childhood obesity crisis.
New UK rules ban junk food ads online and pre-9pm on TV to protect children. With obesity rates twice as high in deprived areas, this public health move aims to narrow health inequalities. Explore the details and debate.
A major UK junk food advertising ban is now in force, targeting HFSS products high in fat, salt, and sugar. Discover the full list of restricted foods and the government's childhood obesity strategy.
A major ban on TV and online ads for unhealthy food and drinks is now law in the UK. The government says it will prevent 20,000 cases of childhood obesity. Find out which products are affected.
A landmark TV and online ban on advertising unhealthy food and drinks is now in effect. The government says it will prevent 20,000 childhood obesity cases. Read the full details.
A landmark UK ban on junk food ads before 9pm and online is now in force. However, a major loophole allows brand advertising like Cadbury's iconic drumming gorilla, sparking criticism from health campaigners.
The World Health Organization now recommends GLP-1 drugs for obesity, a major policy shift. Prof Devi Sridhar explores the tension between pharmaceutical fixes and systemic food reform.
An investigation into China's controversial military-style 'fat prisons', where intense workouts and strict regimes promise rapid weight loss but raise serious safety concerns. Discover the stories behind the trend.
US regulators approve first daily oral weight-loss drug, Wegovy pill, expanding treatment options. Novo Nordisk gains edge in obesity market race. Read the full story.
The UK government has announced a watershed ban on TV ads for HFSS foods before 9pm. Discover how this new policy aims to tackle childhood obesity and its impact on the food industry.
Mounjaro is now India's top-selling drug, overtaking antibiotics. Doctors warn an unregulated boom in weight loss jabs poses serious risks to patients amid a diabetes and obesity epidemic.
Families across five continents reveal their daily struggle against ultra-processed foods targeting children. New Lancet study warns of long-term health harms as obesity rates soar. Read their stories.
With up to 65% of British dogs overweight, a new trial tests 'Ozempic' style jabs for cats and dogs. Could this revolutionise pet health or dampen their joy?
The World Health Organization has issued its first conditional recommendation for weight loss injections to treat obesity, a condition affecting over a billion people globally. Read the latest on access and NHS rollout.
The WHO urges global access to GLP-1 therapies like Mounjaro, calling them a breakthrough in treating obesity, a disease affecting 2 billion by 2030.
The UK government announces milkshakes will no longer be exempt from the sugar tax as part of strengthened measures to tackle childhood obesity. Learn how this affects your favourite drinks.
Health Secretary Wes Streeting announces the soft drinks levy will expand to include milkshakes and milk substitutes to tackle childhood obesity. Read the latest.
New research reveals discontinuing the weight-loss jab Mounjaro leads to significant weight regain and a reversal of cardiometabolic benefits. Learn why long-term treatment may be crucial.
Investigation reveals Nestlé adds up to 7.5g sugar per serving to baby cereals in Africa while European products remain sugar-free. Campaigners accuse company of health risks.
A new study reveals high blood pressure in children has nearly doubled since 2000, now affecting 6.2% of under-19s. Experts call for urgent government action on childhood obesity.
Global study reveals childhood hypertension rates have nearly doubled since 2000, with obesity identified as primary driver. Experts warn of lifelong health consequences.
Shocking new NHS data reveals obesity levels in young children have reached their highest point outside of pandemic years, with stark inequalities between wealthy and deprived areas.
Great British Bake Off star Dame Prue Leith reveals her dramatic change of heart about weight loss injections, warning they're not the miracle solution many believe.
New research reveals how declining public health is creating a ticking time bomb for UK businesses, with rising obesity and inactivity levels threatening productivity and economic growth.
Danish pharmaceutical giant Novo Nordisk has entered a bidding war with Pfizer for obesity-focused biotech firm Metsera, potentially disrupting the US company's planned acquisition in a major power play for obesity treatment dominance.